NCT06279637Recruiting
Joint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes
Joint Patient and Caregiver Intervention for Older African Americans With Poorly Controlled Type 2 Diabetes (Joint Home-DM-BAT)
Source: ClinicalTrials.gov · Last updated 29 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study will test the preliminary efficacy of a joint patient/informal caregiver telephone-delivered intervention that includes diabetes education; problem solving around social needs; and behavioral activation for older African Americans with poorly controlled type 2 diabetes by randomizing 100 patient/caregiver dyads to the Joint Home intervention (n=50) and usual care (n=50) arms. The aims of the study are: Aim 1: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on patient clinical outcomes (hemoglobin A1c, blood pressure, and LDL-Cholesterol). Aim 2: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) Joint Home DM-BAT on patient quality of life. Aim 3: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on caregiver quality of life and caregiver burden.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 19 Feb 2024
- Start date
- 4 Mar 2024
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Medical College of Wisconsin
- Diseases
- Type 2 diabetes
- NCT number
- NCT06279637
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 4 Mar 2024 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Inclusion Criteria:
- Age ≥50 years of age;
- Self-identified as Black/African American;
- Clinical diagnosis of T2DM and poorly controlled, defined as HbA1c ≥8% at the screening visit;
- Able to communicate in English; and
- Has an informal caregiver (family member or close friend willing to participate in the study for 6 months.
- Caregiver Inclusion Criteria:
- Willing to attend 4, one-hour sessions with the study participant;
- Willing to support the study participant for study duration (6 months); and
- Willing to complete brief baseline, 3- and 6-month assessments.
- Patient/Caregiver Exclusion Criteria:
- Mental confusion at screening assessment suggesting significant dementia;
- Alcohol or drug abuse/dependency at screening assessment;
- Active psychosis or acute mental disorder at screening assessment; and
- Life expectancy \<6 months at screening.
Age in the registry: 50 years to 120 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical College of Wisconsin Coordinator of this site? Confirm its status | Milwaukee | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.